HB 767 — Taxes, Business - As introduced, exempts from business tax, receipts from the sale of a prescription drug or medicine with a cost for a 30-day equivalent supply that exceeds the medicare cost threshold for 2025 plan years and services necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of such exempted drugs or medicines. - Amends TCA Title 67, Chapter 4, Part 7.

HB 767 (Current Version)

Current Version text of HB 767.

SENATE BILL 907

By Haile

The document summary and details above are public. The full text is available to signed-in accounts.